MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed Jan 21, 2020
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Tax Payment
Common Stock, par value $0.00001 per share
2020-01-19$7.18/sh−2,044$14,676→ 92,840 total
Footnotes (2)
- [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.
- [F2]Includes 2,893 shares acquired on May 20, 2019 and November 20, 2019 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.